Evidence map›Paper›PMID 34817778›Full record

ArticleMolecular biology reports2022

Evaluation of genetic diversity by morphological, biochemical and molecular markers in sour cherry genotypes.

Mehmet Yaman

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Population structure and genetic diversity inFrontiers in plant science · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Mehmet YamanDepartment of Horticulture, Faculty of Agriculture, Erciyes University, 38038, Kayseri, Turkey. mhmt.-07@hotmail.com.ORCID http://orcid.org/0000-0002-2899-2238
Erciyes University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTurkey's ecological and geographical diversity allows the cultivation of most plant species that have economic importance throughout the country. One of these species, sour cherry, is among the stone fruits that are very important for human health. This study aimed to determine genetic diversity of 21 sour cherry genotypes grown from seed in Kelkit Valley and standard Kutahya cultivars. METHODS AND

resultsMorphological, biochemical, and molecular marker techniques [ISSR (Inter Simple Sequence Repeat)] was used to determine genetic diversity. G11 in terms of fruit characteristics, particularly weight with 4.81 g, and G20 in terms of leaf width produced better results than the other genotypes with 40.10 mm. Molecular marker analysis, a total of 70 bands were obtained from 12 ISSR primers and 49 of them were polymorphic. The mean polymorphism rate in the study was 70%, and the DICE's similarity coefficient of genotypes differed between 0.81 and 0.95. Polymorphism percentages of the ISSR primers varied from 20 to 100%. In biochemical analyzes, G17 with 140.18 mg QE/100 g in total flavonoids content, G19 with 208.63 mg GAE/100 g in total phenolics content, G19 with 8.33 mg cyn-3-gluc/100 g in total anthocyanin content compared to other genotypes prominent genotypes.

conclusionThe use of the obtained results in breeding studies to be carried out on this species, as well as the detection and protection of gene sources, may be beneficial for researchers.

Indexed as

GenotypePolymorphism, GeneticPrunus aviumDNA PrimersGenetic MarkersMicrosatellite RepeatsPhylogenyPlant BreedingDNA PrimersGenetic MarkersBiochemicalFruitGenetic diversityISSRSour cherry

Identifiers

PMID34817778
OpenAlexW3217013193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.